Hexose-specific inhibition in vitro of human red cell Ca2+-ATPase activity
- 21 September 1992
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1110 (1) , 119-122
- https://doi.org/10.1016/0005-2736(92)90302-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study.Hypertension, 1991
- Decreased Ca2(+)-ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitroDiabetes, 1990
- Glycation of calmodulin: chemistry and structural and functional consequencesBiochemistry, 1989
- Altered cation transport in non-insulin-dependent diabetic hypertensionJournal Of Hypertension, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Ca2+-Mg2+-ATPase activity of human red blood cells in healthy and diabetic volunteersJournal of Molecular Medicine, 1987
- The Nonenzymatic Glycation of Proteins and Nucleic Acids, Their Importance for the Development of Diabetic Complications, Possible Molecular Basis of Aging and Autoimmunological ProcessesExperimental and Clinical Endocrinology & Diabetes, 1986
- The Effect of In Vivo Glucose Administration on Human Erythrocyte Ca2+-ATPase Activity and on Enzyme Responsiveness In Vitro to Thyroid Hormone and CalmodulinDiabetes, 1985
- Nonenzymatic Glycosylation and the Pathogenesis of Diabetic ComplicationsAnnals of Internal Medicine, 1984